Peregrine Pharmaceuticals, Inc. (PPHM) Misses Q2 Loss Views; Revs Stronger
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Total costs and expenses: 16.69M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Total costs and expenses: 16.69M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) reported Q2 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $4.23 million versus the consensus estimate of $2.08 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
- Yiren Digital Ltd. (YRD) Reports Q2 Loss of RMB5.11
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
